Prelude Capital Management, LLC Inmune Bio, Inc. Transaction History

Prelude Capital Management, LLC

  • $1.5 Billion
  • Q4 2024

A detailed history of Prelude Capital Management, LLC transactions in Inmune Bio, Inc. stock. As of the latest transaction made, Prelude Capital Management, LLC holds 12,406 shares of INMB stock, worth $106,567. This represents 0.0% of its overall portfolio holdings.

Number of Shares
12,406
Previous 10,727 15.65%
Holding current value
$106,567
Previous $57,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
BUY
$4.4 - $6.43 $7,387 - $10,795
1,679 Added 15.65%
12,406 $57,000
Q3 2024

Nov 14, 2024
BUY
$4.86 - $9.86 $52,133 - $105,768
10,727 New
10,727 $57,000

Others Institutions Holding INMB

# of Institutions
78
Shares Held
7.04M
Call Options Held
202K
Put Options Held
42.9K
View Full List

About Inmune Bio, Inc.

INMB Quotes by TradingView
  • Ticker INMB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 17,946,000
  • Market Cap $154M
  • Description
  • INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on developing drugs to reprogram the patient's innate immune system to treat disease. The company develops and commercializes product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation. Its development programs include INKmune, which focuses on tr...
More about INMB
Track This Portfolio

Track Prelude Capital Management, LLC Portfolio

Follow Prelude Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prelude Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email